AEVA
Aeva Technologies, Inc.
There isn't enough reported data to score AEVA yet.
LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
AEVA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Unavailable |
AEVA's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
AEVA PE Valuation
AEVA has no meaningful PE right now: it lost money over the past year.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
AEVA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect AEVA's losses to shrink, with revenue growing.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
AEVA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.74 | +$2.57 |
| Q2 2026 | -$2.72 | +$2.77 |
| Q1 2026 | -$4.98 | -$2.16 |
| Q4 2025 | -$5.06 | -$2.21 |
| Q3 2025 | -$5.31 | -$2.17 |
| Q2 2025 | -$5.49 | -$2.30 |
| Q1 2025 | -$2.82 | +$0.35 |
| Q4 2024 | -$2.85 | +$0.45 |
AEVA is still losing money, but far less than before: $2.74 per share over the past year, against $5.49 at its worst in mid-2025.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over AEVA on earnings, with more consistent year-over-year improvement.
AEVA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $6.7M | +86% |
| Q2 2026 | $6.1M | +11% |
| Q1 2026 | $6.3M | +86% |
| Q4 2025 | $5.6M | +108% |
| Q3 2025 | $3.6M | +59% |
| Q2 2025 | $5.5M | +174% |
| Q1 2025 | $3.4M | +60% |
| Q4 2024 | $2.7M | +67% |
AEVA has the edge over LCID on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -586% | +340 points |
| Q2 2026 | -563% | +71 points |
| Q1 2026 | -561% | +342 points |
| Q4 2025 | -518% | +752 points |
| Q3 2025 | -927% | +757 points |
| Q2 2025 | -634% | +1797 points |
| Q1 2025 | -903% | +869 points |
| Q4 2024 | -1270% | +1017 points |
AEVA's operating margin was −586% last quarter, up 340 points from the same quarter a year ago.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID's revenue has grown year over year for 11 quarters in a row: $350M last quarter, up 4.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID has the edge over AEVA on profitability, with a higher operating margin.
AEVA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$30.6M | +$3M |
| Q2 2026 | -$31.4M | -$162K |
| Q1 2026 | -$28.1M | +$3.2M |
| Q4 2025 | -$23.7M | -$623K |
| Q3 2025 | -$33.6M | -$7.2M |
| Q2 2025 | -$31.2M | -$1.2M |
| Q1 2025 | -$31.3M | +$1.4M |
| Q4 2024 | -$23M | +$7M |
AEVA has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
AEVA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +11% | +7.1M shares |
| 1 year | +18% | +10.7M shares |
| 3 years | +61% | +27.2M shares |
| 5 years | +69% | +29.3M shares |
AEVA has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
AEVA Net Leverage
AEVA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AEVA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 12.2 | Oversold |
AEVA's weekly RSI is 43 (neutral) and its Stochastic is 12 (oversold).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
AEVA PE vs Consumer Cyclical Sector
AEVA has no meaningful PE right now: it lost money over the past year.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
AEVA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.0 | 1.7% below |
| 20 week MA | $16.0 | 26% below |
| 50 week MA | $16.5 | 28% below |
| 100 week MA | $14.7 | 20% below |
| 200 week MA | $9.65 | 22% above |
AEVA has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
AEVA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $49.3 | $88.8 | +80% |
| 2021 | $88.8 | $41.9 | -53% |
| 2022 | $41.9 | $6.35 | -85% |
| 2023 | $6.35 | $3.79 | -40% |
| 2024 | $3.79 | $4.77 | +26% |
| 2025 | $4.77 | $13.2 | +177% |
| 2026 YTD | $13.2 | $11.8 | -11% |
AEVA has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.